检索

Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity

Zheleznova E., Zhernakova Y., Chazova I., Rogoza A., Zairova A., Shariya M., Yarovaya E., Orlovsky A., Blinova N., Azimova M., Gorieva S., Konosova I.

(Rus)

卷 15, 编号 2 (2018)

Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion

Litvin A., Elfimova E., Chazova I.

(Rus)

卷 15, 编号 1 (2018)

Fixed combination of amlodipine and lisinopril effectiveness in hypertensive smokers

Ostroumova O., Kochetkov A.

(Rus)

卷 14, 编号 4 (2017)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V

Chazova I., Tyulyandin S., Vitsenia M., Poltavskaya M., Gilyarov M., Martynyuk T., Ovchinnikov A., Panchenko E., Fedotkina Y., Stenina M., Trophimova O., Ageev F.

(Rus)

卷 13, 编号 4 (2016)

The control of blood pressure level as the prevention of cognitive impairment

Melnik M., Afonicheva I., Kazyulin A.

(Rus)

卷 13, 编号 3 (2016)

Workplace hypertension": focus on emotional and personality traits in patients

Ostroumova O., Pervichko E., Zinchenko Y.

(Rus)

卷 12, 编号 1 (2015)

The association of arterial hypertension and ischemic heart disease is the main problem in modern cardiology practice

Ostroumova O., Dudaev V., Fomina V.

(Rus)

卷 12, 编号 2 (2015)

Calcium channel blockers: more than 50 years on guard of health

Chazova I., Zhernakova Y.

(Rus)

Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol

Baryshnikov G., Stepanova I., Kudryavtseva N.

(Rus)

Psychosomatic Aspects of Low Adherence to Antihypertensive Therapy in Patients with Arterial Hypertension

Fofanova T., Ageyev F., Kadushina E., Drobizhev M., Smirnova M., Kuzmina A.

(Rus)

(Rus)

Candesartan in treating hypertension

Minushkina L.

(Rus)

卷 10, 编号 2 (2013)

A modern phylogenetic theory of pathology, pathogenesis of essential arterial hypertension and universal algorhythm of damage to the target organs

Titov V.

Effect of the fixed-dose combination Ekvator on blood pressure level and cognitive functions in elderly patients with arterial hypertension

Ostroumova O., Pervichko E.

卷 6, 编号 2 (2009)

Sartans in cardiological practice: new possibilities in therapy of cardiovascular diseases

Smolenskaya O.

Korotkiy put' k zavetnoy tseli – ko-renitek dlya patsienta s AG

Chazova I., Ratova L.

Antagonisty kal'tsiya v lechenii arterial'noy gipertonii (issledovanie ETNA)

Chazova I., Ratova L.

Gipotenzivnaya effektivnost' novoy lekarstvennoy formy metoprolola zamedlennogo vysvobozhdeniya u bol'nykh s arterial'noy gipertoniey

Belousov Y., Leonova M., Erofeeva S.

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Kombinirovannaya terapiya arterial'noy gipertenzii

Chazova I., Ratova L.

卷 18, 编号 1 (2021)

Combined antihypertensive and psychocorrective therapy in patients with arterial hypertension and anxiety-depressive disorders: are there any advantages?

Skibitsky V., Ginter J., Fendrikova A., Sirotenko D.

(Rus)

卷 17, 编号 3 (2020)

Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Khaisheva L., Kameneva T.

(Rus)

卷 16, 编号 2 (2019)

Possibilities of blood pressure and metabolic disorders correction by using diet programs in patients with overweight and obesity

Zhernakova J., Zheleznova E., Chazova I., Blinova N., Ivanov K., Starodubova A.

(Rus)

卷 16, 编号 3 (2019)

Target levels of blood pressure in the elderly and very old patients with chronic kidney disease without frailty

Ostroumova O., Cherniaeva M.

(Rus)

Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy

Avalyan A., Oshchepkova E., Saidova M., Shitov V., Glazkova E., Stenina M., Chazova I.

(Rus)

卷 15, 编号 1 (2018)

The place of intervention methods of treatment of patients with resistant hypertension in clinical practice

Agaeva R., Danilov N., Sagaydak O., Chazova I.

(Rus)

卷 14, 编号 2 (2017)

A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment

Temnikova E.

(Rus)

卷 14, 编号 1 (2017)

Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study)

Efremova Y., Oshchepkova E., Zhernakova Y., Chazova I., Iarovaia E., Shalnova S., Rotar O., Konradi A., Shliakhto E., Boitsov S.

(Rus)

卷 13, 编号 1 (2016)

Loop diuretics in the treatment of hypertension and edema syndrome

Kirichenko A.

(Rus)

卷 12, 编号 1 (2015)

Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases

Dolgusheva Y., Agapova O., Zykov K., Chazova I.

(Rus)

卷 12, 编号 2 (2015)

The hardness of the vessel wall in patients with arterial hypertension

Ostroumova O., Kochetkov A., Kopchenov I., Guseva T., Bondarec O.

(Rus)

Phylogentic theory of pathology. Common phylogenetic features in the pathogenesis of essential arterial hyperntesion and insulin resistance syndrome

Titov V.

(Rus)

Education and self-education of the patients is an important step towards increasing patients acceptance of therapy

Chazova I., Ageev F., Fofanova T., Chikhladze N., Kuznetsova M., Smirnova M., Ostrogorskaya V., Geraschenko Y.

(Rus)

The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS»)

Ostroumova O., Bondarets O., Guseva T.

(Rus)

卷 10, 编号 3 (2013)

Korrektsiya dislipidemiy pri soputstvuyushchey arterial'noy gipertonii s pozitsiy obnovlennoy paradigmy serdechno-sosudistogo riska

Gurevich V.

Effect of adrenalectomy on the condition of the myocardium and arteries in hypertensive patient with primary hyperaldosteronism

Valieva Z., Chikhladze N., Sakhnova T., Blinova E., Panteleev I., Tripoten M., Balakhonova T., Chazova I.

卷 3, 编号 2 (2006)

Korrektsiya disfunktsii endoteliya pri arterial'noy gipertonii: fokus na beta -blokatory

Ostroumova O., Dubinskaya R., Zhukova O.

Optimizatsiya lecheniya patsientov s sochetannymi formami arterial'noy gipertonii i ishemicheskoy bolezni serdtsa

Volkova E.

Arterial'naya gipertoniya i tserebrovaskulyarnye narusheniya

Skvortsova V.

Nefroprotektsiya v lechenii bol'nykh arterial'noy gipertoniey (rezul'taty issledovaniya IRIS)

Chazova I., Ratova L., Kolos I., Kotkina T., Martsevich S., Moiseeva O., Kozyreva M., Dmitrieva N., Semenova Y., Andreeva G., Voronina V., Lukina Y., Ivanenkova P., Serazhim A., Fel'dsherova N.

卷 1, 编号 2 (2004)

Nefroprotektivnyy effekt antigipertenzivnoy terapii: issledovanie IRIS

Ratova L., Chazova I.

卷 17, 编号 4 (2020)

Primary hyperaldosteronism as a possible cause of resistant arterial hypertension

Chikhladze N.

(Rus)

卷 16, 编号 1 (2019)

Diagnosis and treatment of arterial hypertension [Guidelines]

Chazova I., Zhernakova Y.

(Rus)

The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan

Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes

Kovalenko F., Skibitsky V., Fendrikova A.

(Rus)

卷 15, 编号 3 (2018)

Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]

Chazova I., Zhernakova Y.

(Rus)

卷 14, 编号 3 (2017)

The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations

Ostroumova O., Piksina G., Smolyarchuk E., Pavleeva E., Bondarets O.

(Rus)

卷 14, 编号 2 (2017)

Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy?

Martynyuk T., Chazova I.

(Rus)

卷 13, 编号 4 (2016)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide

Ostroumova O., Garelik I., Karavashkina E.

(Rus)

卷 13, 编号 3 (2016)

Zhernakova Y., Chazova I.

(Rus)

卷 12, 编号 1 (2015)

Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach

Zhernakova Y., Sharipova G., Chazova I.

(Rus)

卷 11, 编号 4 (2014)

The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches

Gilyarevsky S., Kuzmina I., Golshmid M.

(Rus)

卷 11, 编号 4 (2014)

Methods of sympathetic activity evaluation in patients with systemic refractory hypertension

Grigin V., Danilov N., Sagaydak O., Shelkova G., Chazova I.

(Rus)

卷 11, 编号 2 (2014)

Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders

Zhernakova Y., Chazova I.

(Rus)

Hypertension treatment features in perimenopausal women

Zhernakova Y., Chazova I.

(Rus)

Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension

Glukhova T., Solgalova S., Alferov V.

卷 3, 编号 2 (2006)

Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom

Chazova I., Martynyuk T.

Vozmozhnosti korrektsii endotelial'noy disfunktsii ingibitorami angiotenzinprevrashchayushchego fermenta

Gorokhovskaya G., Petina M., Akatova E., Aksenov I., Martynov A.

卷 1, 编号 2 (2004)

Gipertonicheskie krizy, sovremennye printsipy terapii

Tereshchenko S.

卷 1, 编号 2 (2004)

Ot idei k klinicheskoy praktike: pervye rezul'taty Rossiyskogo natsional'nogo issledovaniya optimal'nogo snizheniya arterial'nogo davleniya (ROSA)

Chazova I., Belenkov Y.

Povyshenie arterial'nogo davleniya i gipotenzivnaya terapiya pri insul'te

Parfenov V.

卷 17, 编号 4 (2020)

Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus

Zhernakova J., Chazova I.

(Rus)

卷 17, 编号 3 (2020)

Speckle-tracking echocardiography in 3D mode in assessing the deformation of the myocardium and identifying subclinical cardiotoxicity during chemotherapy in breast cancer patients with arterial hypertension

Avalyan A., Saidova M., Oshchepkova E., Chazova I.

(Rus)

卷 16, 编号 3 (2019)

The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus

Zhernakova J., Chazova I., Blinova N.

(Rus)

卷 6, 编号 4 (2009)

Arterial hypertension in the elderly and higher mental functions. Possibilities of an-tihypertensive therapy withArifon retard in the prevention of dementia.

Ostroumova O., Korsakova N., Varako N.

Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension

Agaeva R., Danilov N., Shelkova G., Sagaydak O., Grigin V., Matchin U., Chazova I.

(Rus)

卷 15, 编号 2 (2018)

Blood pressure level and arterial stiffness parameters role in prediction of the antihypertensive therapy efficacy escape phenomenon

Mikhailova O., Elfimova E., Litvin A., Rogoza A.

(Rus)

卷 14, 编号 3 (2017)

Dynamics of clinico-psychological characteristics in patients with obstructive sleep apnea syndrome and arterial hypertension after one month of the use of CPAP therapy

Konovalova K., Elfimova E., Mikhailova O., Fedorova V., Litvin A.

(Rus)

卷 14, 编号 2 (2017)

Clinical efficacy of sympathetic denervation of renal arteries in patients with resistant arterial hypertension as part of annual prospective follow-up

Gapon L., Mikova E., Savelyeva N., Kolunin G., Zherzhova A.

(Rus)

卷 13, 编号 3 (2016)

Prolonged release verapamil: application in clinical practice

Gaponova N., Abdrakhmanov V.

(Rus)

卷 13, 编号 2 (2016)

The major arteries and skin microcirculatory vessels status and antihypertensive therapy effect on them in hypertensive patients with high and very high cardiovascular risk

Mordvinova E., Oshchepkova E., Fedorovich A., Zairova A., Pogorelova O., Tripoten M., Rogoza A.

(Rus)

卷 12, 编号 3 (2015)

The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study)

Oshchepkova E., Dolgusheva I., Zhernakova I., Chazova I., Shal'nova S., Iarovaia E., Rotar' O., Konradi A., Boitsov S.

(Rus)

卷 12, 编号 2 (2015)

Effectiveness and safety of indapamide sustained-release in the treatment of post partial hypertension

Gaisin I., Iskchakova A., Shilina L., Maksimov N., Vavilkina Z., Sava N.

(Rus)

卷 11, 编号 4 (2014)

Dynamics of arterial hypertension and its impact on mortality in the Russian population

Balanova Y., Shalnova S., Deyev A., Konstantinov V., Kapustina A.

(Rus)

Experience of treating hypertension in an outpatient setting: a clinical case

Agafonov A., Khozyainova N., Petruschenkova O.

(Rus)

卷 10, 编号 4 (2013)

Coagulogic risk factors of heart disease in the adult population of Tomsk

Dobrovolsky A., Titaeva E., Yarovaya E., Storozhilova A., Zhernakova Y., Oschepkova E., Panchenko E., Trubacheva I., Serebryakova V., Kaveshnikova V., Chazova I., Karpov R.

卷 10, 编号 3 (2013)

Primenenie diuretikov u bol'nykh arterial'noy gipertoniey s metabolicheskimi narusheniyami

Zhernakova Y., Chazova I.

Evaluation of the antihypertensive efficacy and safety of moxonidine in the treatment of uncomplicated hypertensive crisis

Tereshchenko S., Gaponova N., Abdrakhmanov V.

卷 3, 编号 2 (2006)

Primenenie ingibitorov angiotenzinprevrashchayushchego fermenta v lechenii arterial'noy gipertonii

Galyavich A.

Effektivnost' i bezopasnost' sovremennykh mochegonnykh preparatov u patsientov s arterial'noy gipertoniey oslozhnennogo techeniya

Chazova I.

Otsenka effektivnosti moeksiprila u bol'nykh myagkoy i umerennoy arterial'noy gipertoniey s gipertrofiey miokarda levogo zheludochka (issledovanie ENIGMA)

Belenkov Y., Chazova I., Ratova L., Ataullakhanova D., Karpov R., Shlyakhto E., Fomin I.

Rossiyskoe mnogotsentrovoe issledovanie FAGOT (farmakoekonomicheskaya otsenka ispol'zovaniya ingibitorov angiotenzinprevrashchayushchego fermenta v ambulatornom lechenii bol'nykh arterial'noy gipertoniey oslozhnennogo techeniya)

Chazova I.

Vozmozhnosti obespecheniya nefroprotektsii na fone blokady retseptorov angiotenzina II kandesartanom u bol'nykh arterial'noy gipertoniey

Chikhladze N., Chazova I.

卷 18, 编号 2 (2021)

Comparative characteristics of indicators of peripheral arterial and central aortic pressure, remodeling of the left ventricular myocardium in salt-sensitive and salt-resistant patients with arterial hypertension

Skibitskiy V., Vasil'ev V., Fendrikova A., Pyatakov S.

(Rus)

卷 17, 编号 4 (2020)

The place of fixed antihypertensive drugs in modern therapy of arterial hypertension

Pinchuk T., Orlova N.

(Rus)

卷 17, 编号 2 (2020)

Features of cerebral autoregulation and reactivity in patients with arterial hypertension in older age groups with orthostatic hypotensive reactions

Atyunina I., Oshchepkova E., Rogoza A.

(Rus)

卷 16, 编号 2 (2019)

Orthostatic reactions and cognitive dysfunctions in elderly and senile patients with arterial hypertension

Atyunina I., Oschepkova E., Rogoza A., Lazareva N.

(Rus)

卷 6, 编号 4 (2009)

The condition of parameters of memory, attention and thinking at men of young age officers under the contractwith arterial hypertension.

Davidovich I., Afonaskov O., Staroverova Y.